1 Result(s)

Article

Severe prolonged neutropenia following administration of tocilizumab in a patient affected by COVID-19: a case report and brief review of the literature

Tocilizumab is one of the newest therapeutic options for the acute respiratory distress syndrome (ARDS) caused by the recently discovered severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) β-coronavi...

Luca Bernardo, Stefania Del Sesto, Laura Giordano… in Drugs & Therapy Perspectives (2020)